학술논문

Phase 1 trial supports safety and mechanism of action of peptide immunotherapy for peanut allergy
Document Type
Article
Source
In: Allergy: European Journal of Allergy and Clinical Immunology. (Allergy: European Journal of Allergy and Clinical Immunology, February 2024, 79(2):485-498)
Subject
Language
English
ISSN
13989995
01054538